Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?

Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?

Background/AimsSpontaneous HBeAg seroconversion occurs frequently in the immune reactive phase in HBeAg-positive chronic hepatitis B (CHB). Therefore, observation for 3-6 months before commencing antiviral therapy is recommended in patients with alanine aminotransferase (ALT) levels that exceed twic...

Full description

Bibliographic Details
Main Authors: Byung-Cheol Song, Yoo-Kyung Cho, Hyeyoung Jwa, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2014-12-01
Series:Clinical and Molecular Hepatology
Subjects:
Hepatitis B virus, chronic hepatitis B
acute exacerbation of hepatitis B, HBV genotype
Online Access:http://e-cmh.org/upload/pdf/cmh-20-355.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-20-355.pdf

Similar Items